Section 1: 10-Q (10-Q)

Total Page:16

File Type:pdf, Size:1020Kb

Section 1: 10-Q (10-Q) Section 1: 10-Q (10-Q) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ Form 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 Or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Commission File Number) 001-32410 CELANESE CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 98-0420726 (State or Other Jurisdiction of (I.R.S. Employer Incorporation or Organization) Identification No.) 222 W. Las Colinas Blvd., Suite 900N Irving, TX 75039-5421 (Address of Principal Executive Offices) (Zip Code) (972) 443-4000 (Registrant's telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. Large accelerated filer þ Accelerated filer o Non-accelerated filer o (Do not check if a smaller reporting company) Smaller reporting company o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ The number of outstanding shares of the registrant's Series A common stock, $0.0001 par value, as of October 11, 2016 was 143,199,495. Table of Contents CELANESE CORPORATION AND SUBSIDIARIES Form 10-Q For the Quarterly Period Ended September 30, 2016 TABLE OF CONTENTS Page PART I - FINANCIAL INFORMATION Item 1. Financial Statements 3 a) Unaudited Interim Consolidated Statements of Operations for the three and nine months ended September 30, 2016 and 2015 3 b) Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2016 and 2015 4 c) Unaudited Consolidated Balance Sheets as of September 30, 2016 and December 31, 2015 5 d) Unaudited Interim Consolidated Statement of Equity for the nine months ended September 30, 2016 6 e) Unaudited Interim Consolidated Statements of Cash Flows for the nine months ended September 30, 2016 and 2015 7 f) Notes to the Unaudited Interim Consolidated Financial Statements 8 Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 41 Item 3. Quantitative and Qualitative Disclosures about Market Risk 55 Item 4. Controls and Procedures 55 PART II - OTHER INFORMATION Item 1. Legal Proceedings 56 Item 1A. Risk Factors 56 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 57 Item 3. Defaults Upon Senior Securities 57 Item 4. Mine Safety Disclosures 57 Item 5. Other Information 57 Item 6. Exhibits 58 Signatures 59 2 Table of Contents Item 1. Financial Statements CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended Nine Months Ended September 30, September 30, 2016 2015 2016 2015 (In $ millions, except share and per share data) Net sales 1,323 1,413 4,078 4,340 Cost of sales (968) (1,110) (2,995) (3,281) Gross profit 355 303 1,083 1,059 Selling, general and administrative expenses (81) (93) (232) (297) Amortization of intangible assets (3) (3) (7) (9) Research and development expenses (20) (19) (58) (98) Other (charges) gains, net (3) (4) (12) (19) Foreign exchange gain (loss), net (1) 3 1 3 Gain (loss) on disposition of businesses and assets, net (1) (1) 1 (8) Operating profit (loss) 246 186 776 631 Equity in net earnings (loss) of affiliates 41 50 114 138 Interest expense (28) (29) (91) (86) Refinancing expense (4) — (6) — Interest income — — 1 1 Dividend income - cost investments 26 26 82 80 Other income (expense), net — (8) (2) (6) Earnings (loss) from continuing operations before tax 281 225 874 758 Income tax (provision) benefit (15) (74) (127) (170) Earnings (loss) from continuing operations 266 151 747 588 Earnings (loss) from operation of discontinued operations (4) — (3) (3) Income tax (provision) benefit from discontinued operations 1 — 1 1 Earnings (loss) from discontinued operations (3) — (2) (2) Net earnings (loss) 263 151 745 586 Net (earnings) loss attributable to noncontrolling interests (1) 10 (5) 16 Net earnings (loss) attributable to Celanese Corporation 262 161 740 602 Amounts attributable to Celanese Corporation Earnings (loss) from continuing operations 265 161 742 604 Earnings (loss) from discontinued operations (3) — (2) (2) Net earnings (loss) 262 161 740 602 Earnings (loss) per common share - basic Continuing operations 1.84 1.07 5.08 3.97 Discontinued operations (0.02) — (0.01) (0.01) Net earnings (loss) - basic 1.82 1.07 5.07 3.96 Earnings (loss) per common share - diluted Continuing operations 1.83 1.07 5.06 3.93 Discontinued operations (0.02) — (0.01) (0.01) Net earnings (loss) - diluted 1.81 1.07 5.05 3.92 Weighted average shares - basic 144,005,098 149,800,029 145,959,821 152,153,057 Weighted average shares - diluted 144,601,465 151,004,081 146,585,560 153,420,449 See the accompanying notes to the unaudited interim consolidated financial statements. 3 Table of Contents CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Three Months Ended Nine Months Ended September 30, September 30, 2016 2015 2016 2015 (In $ millions) Net earnings (loss) 263 151 745 586 Other comprehensive income (loss), net of tax Unrealized gain (loss) on marketable securities (1 ) 1 — — Foreign currency translation (8 ) (11 ) 38 (130 ) Gain (loss) on cash flow hedges — (1 ) 1 2 Pension and postretirement benefits — — (1 ) 1 Total other comprehensive income (loss), net of tax (9 ) (11 ) 38 (127 ) Total comprehensive income (loss), net of tax 254 140 783 459 Comprehensive (income) loss attributable to noncontrolling interests (1 ) 10 (5 ) 16 Comprehensive income (loss) attributable to Celanese Corporation 253 150 778 475 See the accompanying notes to the unaudited interim consolidated financial statements. 4 Table of Contents CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED BALANCE SHEETS As of As of September 30, December 31, 2016 2015 (In $ millions, except share data) ASSETS Current Assets Cash and cash equivalents (variable interest entity restricted - 2016: $22; 2015: $7) 1,252 967 Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2016: $6; 2015: $6; variable interest entity restricted - 2016: $5; 2015: $6) 791 706 Non-trade receivables, net 214 285 Inventories 652 682 Deferred income taxes — 68 Marketable securities, at fair value 34 30 Other assets 35 49 Total current assets 2,978 2,787 Investments in affiliates 864 838 Property, plant and equipment (net of accumulated depreciation - 2016: $2,228; 2015: $2,039; variable interest entity restricted - 2016: $744; 2015: $772) 3,578 3,609 Deferred income taxes 216 222 Other assets (variable interest entity restricted - 2016: $9; 2015: $13) 290 300 Goodwill 712 705 Intangible assets (net of accumulated amortization - 2016: $542; 2015: $528; variable interest entity restricted - 2016: $26; 2015: $27) 119 125 Total assets 8,757 8,586 LIABILITIES AND EQUITY Current Liabilities Short-term borrowings and current installments of long-term debt - third party and affiliates 92 513 Trade payables - third party and affiliates 591 587 Other liabilities 299 330 Deferred income taxes — 30 Income taxes payable 116 90 Total current liabilities 1,098 1,550 Long-term debt, net of unamortized deferred financing costs 2,923 2,468 Deferred income taxes 139 136 Uncertain tax positions 101 167 Benefit obligations 1,124 1,189 Other liabilities 221 247 Commitments and Contingencies Stockholders' Equity Preferred stock, $0.01 par value, 100,000,000 shares authorized (2016 and 2015: 0 issued and outstanding) — — Series A common stock, $0.0001 par value, 400,000,000 shares authorized (2016: 167,476,602 issued and 143,199,495 outstanding; 2015: 166,698,787 issued and 146,782,297 outstanding) — — Series B common stock, $0.0001 par value, 100,000,000 shares authorized (2016 and 2015: 0 issued and outstanding) — — Treasury stock, at cost (2016: 24,277,107 shares; 2015: 19,916,490 shares) (1,331 ) (1,031 ) Additional paid-in capital 140 136 Retained earnings 4,211 3,621 Accumulated other comprehensive income (loss), net (310 ) (348 ) Total Celanese Corporation stockholders' equity 2,710 2,378 Noncontrolling interests 441 451 Total equity 3,151 2,829 Total liabilities and equity 8,757 8,586 See the accompanying notes to the unaudited interim consolidated financial statements. 5 Table of Contents CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED INTERIM CONSOLIDATED STATEMENT OF EQUITY Nine Months Ended September
Recommended publications
  • For Our Customers, Shareholders, Employees and Stakeholders
    for our customers, shareholders, employees and stakeholders 2005 Annual Report Creating Value In 2005, we continued to accelerate Celanese toward greater growth and profitability. We started the year with a successful initial public offering and ended 2005 as a leaner, faster and more agile company with strong business results. We also strengthened our leading global positions in key regions. Celanese’s combined net sales were $6.1 billion, up 22% from the previous year. As a global hybrid chemical company, we executed our strategy, grew our businesses and built on our track record of productivity and operational excellence. Our 9,300 associates delivered terrific results. Here are some of our more significant achievements in 2005: > Completed an initial public offering and, through the private equity sponsorship of The Blackstone Group, transformed our company from a German based company with a dual listing to a U.S. headquartered company listed on the New York Stock Exchange. > Acquired Acetex and Vinamul and began integration activities. > Made steady progress on our China strategy and announced plans to develop our Nanjing site into an integrated, chemical complex. > Restructured our Acetate Products segment and expanded its China ventures. > Continued to optimize our portfolio through divestitures of non-core applications or businesses. > Lowered our purchasing and underlying SG&A expenses through cost reductions and headquarters consolidation. > Received recognition for our improved performance with an upgrade from a credit rating agency. We have made tremendous progress and have identified a clear path to build on our success. Celanese has six key drivers to increase value: > Utilize our attractive, hybrid structure of basic and higher value-added downstream businesses to reduce cyclicality and provide more stable earnings.
    [Show full text]
  • Section 1: 10-K (10-K)
    Section 1: 10-K (10-K) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________ Form 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Commission File Number) 001-32410 CELANESE CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 98-0420726 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 222 West Las Colinas Blvd., Suite 900N, Irving, TX 75039-5421 (Address of Principal Executive Offices) (Zip Code) (972) 443-4000 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act Title of Each Class Name of Each Exchange on Which Registered Common Stock, par value $0.0001 per share New York Stock Exchange 3.250% Senior Notes due 2019 New York Stock Exchange 1.125% Senior Notes due 2023 New York Stock Exchange 1.250% Senior Notes due 2025 New York Stock Exchange 2.125% Senior Notes due 2027 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes þ No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
    [Show full text]
  • Section 1: 10-K (10-K) Table of Contents
    Toggle SGML Header (+) Section 1: 10-K (10-K) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ Form 10-K ; ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Commission File Number) 001-32410 CELANESE CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 98-0420726 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 222 West Las Colinas Blvd., Suite 900N Irving, TX 75039-5421 (Address of Principal Executive Offices) (Zip Code) (972) 443-4000 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act Title of Each Class Name of Each Exchange on Which Registered Series A Common Stock, par value $0.0001 per share New York Stock Exchange 3.250% Senior Notes due 2019 New York Stock Exchange 1.125% Senior Notes due 2023 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ; No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No ; Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • Form 10-K CELANESE CORPORATION
    Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________ Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Commission File Number) 001-32410 CELANESE CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 98-0420726 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 222 W. Las Colinas Blvd., Suite 900N Irving, TX 75039-5421 (Address of Principal Executive Offices and zip code) (972) 443-4000 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.0001 per share CE New York Stock Exchange 1.125% Senior Notes due 2023 CE /23 New York Stock Exchange 1.250% Senior Notes due 2025 CE /25 New York Stock Exchange 2.125% Senior Notes due 2027 CE /27 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☑ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☑ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • Celanese Corp. (CE) Celanese Corp
    Corrected Transcript 19-Jun-2017 Celanese Corp. (CE) Celanese Corp. and The Blackstone Group LP Acetate Tow Joint Venture Agreement Call Total Pages: 16 1-877-FACTSET www.callstreet.com Copyright © 2001-2017 FactSet CallStreet, LLC Celanese Corp. (CE) Celanese Corp. and The Blackstone Group LP Acetate Tow Joint Venture Agreement Corrected Transcript Call 19-Jun-2017 CORPORATE PARTICIPANTS Surabhi Varshney Scott McDougald Sutton Vice President-Investor Relations, Celanese Corp. Chief Operating Officer, Celanese Corp. Mark C. Rohr Christopher W. Jensen Chairman & Chief Executive Officer, Celanese Corp. Chief Financial Officer, Celanese Corp. ................................................................................................................................................................................................................................ OTHER PARTICIPANTS Jeffrey Schnell James Sheehan Analyst, Jefferies LLC Analyst, SunTrust Robinson Humphrey, Inc. Frank J. Mitsch Kevin W. McCarthy Analyst, Wells Fargo Securities LLC Analyst, Vertical Research Partners LLC P.J. Juvekar Ryan Berney Analyst, Citigroup Global Markets, Inc. (Broker) Analyst, Goldman Sachs & Co. LLC David I. Begleiter John Roberts Analyst, Deutsche Bank Securities, Inc. Analyst, UBS Securities LLC Jeffrey J. Zekauskas John P. Babcock Analyst, JPMorgan Securities LLC Analyst, Bank of America Merrill Lynch 2 1-877-FACTSET www.callstreet.com Copyright © 2001-2017 FactSet CallStreet, LLC Celanese Corp. (CE) Celanese Corp. and The Blackstone Group LP Acetate Tow Joint Venture Agreement Corrected Transcript Call 19-Jun-2017 MANAGEMENT DISCUSSION SECTION Operator: Good morning and welcome to the Celanese Blackstone Acetate Tow JV Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Surabhi Varshney.
    [Show full text]
  • Blackstone/Celanese Mergers and Acquisitions Valuation Due Diligence Deal Structuring
    FINANCE SIMULATION FOR COURSES IN: PRIVATE EQUITY BLACKSTONE/CELANESE MERGERS AND ACQUISITIONS VALUATION DUE DILIGENCE DEAL STRUCTURING BY NABIL N. EL-HAGE AND TIMOTHY A. LUEHRMAN HARVARD BUSINESS SCHOOL hbsp.harvard.edu FINANCE SIMULATION BLACKSTONE/CELANESE In 2003, The Blackstone Group LP, a private equity firm, considered a friendly takeover of the global chemical manufacturer Celanese AG. If successful, the transaction would be the deal. Students play through three rounds largest European public-to-private acquisition in beginning with an initial valuation of Celanese, history. In this multi-player simulation, students then conduct due diligence, establish deal assume the roles of Blackstone or Celanese and terms, and respond to bids while considering recreate the circumstances of this landmark the interests of other stakeholders. Finance Simulation Blackstone/Celanese prepare analyze decide operating income balance cash due purchase sources & exit value chemical assumptions statement sheet flow diligence price uses of & IRR comparables inputs funds Overview Historical Data Chat Confidential Info EBITDA Copy to Clipboard 1998 to 2002 2003 2004 2005 2006 2007 2008 700 OPERATING ASSUMPTIONS Sales Growth -8.60% 0.00% 0.50% 1.60% 5.20% 1.30% COGS as a % of Sales 62.20% 64.00% 65.00% 67.00% 69.00% 69.00% 0 2004 2008 Gross Margin 37.80% 36.00% 35.00% 33.00% 31.00% 31.00% SG&A as a % of Sales 27.20% 25.30% 25.30% 25.30% 25.30% 25.30% CAPITAL CASH FLOWS Potential Additional SG&A Reductions -12.0 8.0 -24.0 -24.0 -42.0 400 SG&A as a % of Sales After Reduction 27.20% 24.99% 25.50% 24.70% 24.73% 24.32% EBITDA Margin 10.60% 11.01% 9.50% 8.30% 6.27% 6.68% EBIT Margin 0 4.24% 4.75% 3.24% 2.49% 0.53% 1.00% 2004 2008 CapEx 208.0 231.0 230.0 234.0 232.0 233.0 Blackstone Monitoring Fee 5.0 5.0 5.0 5.0 5.0 Additional Special Charges 15.0 17.2 14.3 14.7 16.2 The simulation includes several tools to help students determine the value of Celanese.
    [Show full text]
  • Section 1: 10-Q (10-Q)
    Section 1: 10-Q (10-Q) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ Form 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 Or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Commission File Number) 001-32410 CELANESE CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 98-0420726 (State or Other Jurisdiction of (I.R.S. Employer Incorporation or Organization) Identification No.) 222 W. Las Colinas Blvd., Suite 900N Irving, TX 75039-5421 (Address of Principal Executive Offices) (Zip Code) (972) 443-4000 (Registrant's telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.
    [Show full text]
  • Blackstone/ Celanese
    Finance Simulation FOR COURSES IN: Private Equity Mergers and Acquisitions BLACKSTONE/ Valuation Due Diligence CELANESE Deal Structuring by Nabil N. El-Hage and Timothy A. Luehrman Harvard Business School Finance Simulation: Blackstone/Celanese In 2003, The Blackstone Group LP, a private the roles of Blackstone or Celanese and recreate equity firm, considered a friendly takeover of the circumstances of this landmark deal. Students the global chemical manufacturer Celanese AG. play through three rounds beginning with an initial If successful, the transaction would be the largest valuation of Celanese, then conduct due diligence, European public-to-private acquisition in history. establish deal terms, and respond to bids while In this multi-player simulation, students assume considering the interests of other stakeholders. Finance Simulation Blackstone/Celanese prepare analyze decide operating income balance cash due purchase sources & exit value chemical assumptions statement sheet flow diligence price uses of & IRR comparables inputs funds Overview Historical Data Chat Confidential Info EBITDA Copy to Clipboard 1998 to 2002 2003 2004 2005 2006 2007 2008 700 OPERATING ASSUMPTIONS Sales Growth -8.60% 0.00% 0.50% 1.60% 5.20% 1.30% COGS as a % of Sales 62.20% 64.00% 65.00% 67.00% 69.00% 69.00% 0 2004 2008 Gross Margin 37.80% 36.00% 35.00% 33.00% 31.00% 31.00% SG&A as a % of Sales 27.20% 25.30% 25.30% 25.30% 25.30% 25.30% CAPITAL CASH FLOWS Potential Additional SG&A Reductions -12.0 8.0 -24.0 -24.0 -42.0 400 SG&A as a % of Sales After Reduction 27.20% 24.99% 25.50% 24.70% 24.73% 24.32% EBITDA Margin 10.60% 11.01% 9.50% 8.30% 6.27% 6.68% EBIT Margin 0 4.24% 4.75% 3.24% 2.49% 0.53% 1.00% 2004 2008 CapEx 208.0 231.0 230.0 234.0 232.0 233.0 Blackstone Monitoring Fee 5.0 5.0 5.0 5.0 5.0 Additional Special Charges 15.0 17.2 14.3 14.7 16.2 The simulation includes several tools to help students determine the value of Celanese.
    [Show full text]
  • Section 1: 10-K (10-K)
    Toggle SGML Header (+) Section 1: 10-K (10-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Commission File Number) 001-32410 CELANESE CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 98-0420726 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 222 West Las Colinas Blvd., Suite 900N Irving TX 75039-5421 (Address of Principal Executive Offices) (Zip Code) (972) 443-4000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act Name of Each Exchange Title of Each Class on Which Registered Series A Common Stock, par value $0.0001 per share New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • March 25, 2021 Disclosures
    2021 Investor Day March 25, 2021 Disclosures Forward-Looking Statements This presentation contains "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues, synergies, performance, capital expenditures, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this presentation. These risks and uncertainties include, among other things: the extent to which the COVID-19 pandemic continues to adversely impact the economic environment, market demand and our operations, as well as the pace of any economic recovery; changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, mobility, textiles, medical, electronics and construction industries; changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; the ability
    [Show full text]
  • Final Biological Assessment
    Biological Assessment Celanese Methanol Project 72388001.00 Biological Assessment Celanese Methanol Project Document Information Prepared for Celanese Ltd. Project Name Celanese Methanol Project Project Number 72388001.00 Project Manager Anne Allen Date February 2013 Prepared for: Celanese Ltd. 9502 Bayport Blvd. Pasadena, TX 77507-1498 Prepared by: Cardno ENTRIX 5252 Westchester, Suite 250, Houston, Texas 77005 Tel 713 666 6223 Fax 713 666 5227 Toll-free 800 368 7511 www.cardnoentrix.com February 2013 Cardno ENTRIX Document Information i Biological Assessment Celanese Methanol Project This Page Intentionally Left Blank ii Document Information Cardno ENTRIX February 2013 Biological Assessment Celanese Methanol Project Table of Contents Executive Summary ...............................................................................................................1-1 1 Introduction ...................................................................................................................1-1 1.1 Regulatory Setting ............................................................................................................ 1-1 1.1.1 Clean Air Act ..................................................................................................... 1-1 1.1.2 Endangered Species Act .................................................................................. 1-2 2 Project Description .......................................................................................................2-1 2.1 Purpose and Need...........................................................................................................
    [Show full text]
  • Top 300 Organizations Granted U.S. Patents in 2014
    Top 300 Organizations Granted U.S. Patents in 2014 Are more patents better? IPO does not attempt to answer the question above. IPO publishes patent owner lists as an information service for IPO members. This list of organizations that received the most U.S. utility patents is being published by IPO for the 32st consecutive year. It is based on data obtained from the U.S. Patent & Trademark Office. Patents granted to parent and subsidiary companies are combined in many instances. See the end notes for more information. IPO makes reasonable efforts to avoid errors, but cannot guarantee accuracy. June 15, 2015 2014 Patent Owners Numerical Listing Use care in interpreting the “percent change from 2013” column. The total number of patents granted by the USPTO in 2014 was 300,678, up 8 percent from 2013. The percent change for an individual organization could be affected by mergers, acquisitions, divestitures, different treatment of subsidiaries in 2013 and 2014, and many other factors. Percent Percent 2014 Change 2014 Change Rank Organization Patents From 2013 Rank Organization Patents From 2013 1 International Business Machines 7,481 10.2 39 Honeywell International Inc. 1,031 7.3 Corp. 40 Robert Bosch GmbH 985 11.4 2 Samsung Electronics Co., Ltd. 4,936 6.1 41 United Technologies Corp. 983 69.5 3 Canon K.K. 4,172 6.5 42 Boston Scientific Corp. 976 8.0 4 Sony Corp. 3,214 -3.1 43 Fujifilm Corp. 925 7.2 5 Microsoft Corp. 2,983 6.0 Koninklijke Philips N.V. 925 -7.9 6 Google, Inc.
    [Show full text]